cellular cardiomyoplasty (injection of cells only, direct/indirect) |
minimal invasive |
lack of knowledge of cell function, cell loss, effect to only endocardium |
[76,77] |
in situ engineering (injection of cells and biomaterial) |
biomaterial act as supporting matrix while cells will regenerate infarction |
infancy stage |
[78,79] |
injection of biomaterials alone |
matrix for homing autologous progenitor cells |
immunogenicity, as only natural polymers have been suggested |
[13] |
left ventricular restraints (wrapping up the ventricle with biopolymer) |
does not involve cell injection |
prevents remodelling but does not repair damaged area |
[80] |
tissue engineering |
ensures cells are delivered to desired area with minimal loss |
involves open heart surgery, more work is required to determine suitable cell type and material |
[81,82] |